Naissan Wesley, MD
Dermatology · Los Angeles, CANPI 1922130608
Payments from drug & device makers
Across 195 payments — averaging $188.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evolved By Nature, Inc.$31K
- AbbVie$1K
- Galderma Laboratories, L.p.$953
- Johnson & Johnson$563
- Biofrontera Inc.$495
- Novartis$318
- plus $2K from 25 others
What the payments were for
- Consulting fees$30,59483%
- Speaking & faculty fees$8002%
- Food & beverage$5,19914%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evolved By Nature, Inc. | 4 | $30,594 |
| AbbVie(2 entities) | 46 | $1,376 |
| Galderma Laboratories, L.p. | 12 | $953 |
| Johnson & Johnson | 19 | $563 |
| Biofrontera Inc. | 3 | $495 |
| Novartis | 19 | $318 |
| Merz North America, Inc. | 8 | $243 |
| Revance Therapeutics, Inc. | 6 | $216 |
| Almirall LLC | 8 | $200 |
| LEO Pharma Inc. | 10 | $197 |
| Bristol Myers Squibb | 11 | $172 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $145 |
| Sun Pharmaceutical Industries Inc. | 6 | $137 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $132 |
| Amgen | 5 | $128 |
| Lilly USA, LLC | 6 | $124 |
| Incyte Corporation | 4 | $91 |
| E.r. Squibb & Sons, L.L.C. | 2 | $70 |
| Aclaris Therapeutics, Inc. | 3 | $68 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Glenmark Therapeutics Inc. | 1 | $66 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $66 |
| EPI Health, LLC | 3 | $52 |
| Botanix SB Inc | 2 | $42 |
| UCB, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Sanofi | 1 | $19 |
| Pfizer | 1 | $19 |
| Medline Industries LP | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,663 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tretinoin | 14 | $1,214 |
| Ciclopirox | 16 | $639 |
| Mupirocin | 17 | $139 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Los Angeles
- Howard SofenLos Angeles$16.1M
- April ArmstrongLos Angeles$6.2M
- Christopher HoLos Angeles$2M
- Pearl GrimesLos Angeles$1.6M
- Jonathan CotliarLos Angeles$1.4M
- Jennifer HsiaoLos Angeles$1.1M
- Derek JonesLos Angeles$1.1M
- Roger LoLos Angeles$727K
- Vivian LaquerIrvine$20.9M
- Raja SivamaniSacramento$11.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.